{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-004179","form_type":"8-K","ticker":"YCBD","cik":"0001644903","company_name":"cbdMD, Inc.","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.979028+00:00","generated_at":"2026-06-19T04:59:07.257758+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"cbdMD annual meeting elects directors, authorizes reverse split; appoints new Chairman, President, CFO","bullets":["Shareholders elected four directors: Bakari Sellers, William F. Raines III, Scott G. Stephen, Dr. Sibyl Swift; ratified Cherry Bekaert as auditor.","Approved reverse stock split authorization (1:20 to 1:50 ratio, board discretion, within one year).","Board appointed Scott Stephen as Chairman, Kevin MacDermott as President, T. Ronan Kennedy as CFO/COO/Secretary/Treasurer.","Independent chairman to receive additional $22,500 annual fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-004179","json":"https://secwatch.observer/filing/0001437749-23-004179.json","markdown":"https://secwatch.observer/filing/0001437749-23-004179.md","text":"https://secwatch.observer/filing/0001437749-23-004179.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004179/0001437749-23-004179-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004179/ycbd20230220_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T04:59:07.257758+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25dd0e69f1491c6605df335deee0bde9832bf7ad","claim":"cbdMD, Inc. shareholders approved Ratification of Cherry Bekaert LLP as independent registered public accounting firm at the 2023-02-16 meeting.","evidence_excerpt":"Proposal 2: The appointment of Cherry Bekaert LLP as our independent registered public accounting firm was ratified, based upon the following final tabulation of votes: “For ” “Against ” “Abstain ” 29,188,087 80,516 694,108","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004179/0001437749-23-004179-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-02-16"}],"fact_type":"shareholder_vote"},{"claim_id":"50702c35b74f73e30564d1f296c78652f2e5068d","claim":"cbdMD, Inc. shareholders approved Amendment to Articles of Incorporation to effect a reverse stock split at a ratio ranging from 1:20 to 1:50 at the 2023-02-16 meeting.","evidence_excerpt":"Proposal 3: The amendment to our Articles of Incorporation, as amended, at the discretion of the board of directors, to effect a reverse stock split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-twenty (1:20) to one-for-fifty (1:50), at any time prior to the one-year anniversary date of the annual meeting, with the exact ratio to be determined by the board was approved, based upon the following final tabulation of votes: “For ” “Against ” “Abstain ” 26,518,758 3,437,896 6,057","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004179/0001437749-23-004179-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-02-16"}],"fact_type":"shareholder_vote"},{"claim_id":"c6981a3014382c9c5ca15f534eed365187910e24","claim":"cbdMD, Inc. shareholders approved Election of Directors at the 2023-02-16 meeting.","evidence_excerpt":"Proposal 1: The following directors were elected at the 2023 annual meeting of shareholders to hold office until the 2024 annual meeting of shareholders or their earlier resignation, removal or death: Directors “For ” “Against ” Broker Non-Votes Bakari Sellers 26,273,192 3,119,747 569,772 William F. Raines, III 26,321,975 3,070,914 569,772 Scott G. Stephen 26,195,800 3,197,089 569,772 Dr. Sibyl Swift 26,887,466 2,505,473 569,772","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004179/0001437749-23-004179-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-02-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}